Cost and effectiveness studies in non-small cell lung cancer

Basit Öğe Kaydı
dc.contributor.authorYalçın Balçık, Pınar
dc.contributor.authorTaşkaya, Serap
dc.contributor.authorŞahin, Bayram
dc.date.accessioned13.07.201910:50:10
dc.date.accessioned2019-07-16T08:22:37Z
dc.date.available13.07.201910:50:10
dc.date.available2019-07-16T08:22:37Z
dc.date.issued2014
dc.departmentSağlık Hizmetleri Meslek Yüksekokulu
dc.description.abstractLung cancer disease diagnosis and treatment is costly. As the numbers of inflicted rise so does the economic burden assumed for this cancer type. When the treatment expenditures are considered for all types of cancer, the lung cancer is thought to occupy a 20% share. The disease examined in two basic groups as small-cell lung cancer and non-small cell lung cancer (NSCLC) is the most frequently encountered type of its kind nationally and in the World. This study considers the cost, effectiveness and cost effectiveness of platinum based chemotherapy medications with active ingredients pemetrexed and gemcitabine used for NSCLC. A review of studies relevant to the advanced stage NSCLC where majority of patients are positioned is foreseen to be useful to the decision makers since policy makers, regulating authorities and physicians require more information due to increased overall finance and costs, as well as treatment cost effectiveness. Furthermore, due to the entry attempt of pemetrexed active ingredient to the list of reimbursed medications for the first stage lung cancer treatment, it is assumed that a review of studies containing pemetrexed and gemcitabine will draw the attention of decision makers at the Social Security Instutition. © 2014, Gulhane Military Medical Academy. All rights reserved.
dc.identifier.doi10.5455/pmb.1-1403099245
dc.identifier.endpage64en_US
dc.identifier.issn1303-734X
dc.identifier.issue6en_US
dc.identifier.scopusqualityN/A
dc.identifier.startpage55en_US
dc.identifier.urihttps://dx.doi.org/10.5455/pmb.1-1403099245
dc.identifier.urihttps://hdl.handle.net/20.500.12451/2607
dc.identifier.volume13en_US
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherGulhane Military Medical Academy
dc.relation.ispartofTAF Preventive Medicine Bulletin
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCost
dc.subjectEffectiveness
dc.subjectLung Cancer
dc.titleCost and effectiveness studies in non-small cell lung cancer
dc.title.alternativeKüçük hücreli dişi akciğer kanserinde maliyet ve etkililik çalişmalari
dc.typeArticle

Dosyalar

Koleksiyon

Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu